Sponsor Pipeline

Chengdu Kanghong Biotech Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07514975 First-In-Human Study of KHN922 for Injection Advanced Solid Tumors Cancer Not Yet Recruiting
Phase 1
NCT06885645 First-In-Human Study in Participants With Advanced Solid Tumors Advanced Solid Tumors Not Yet Recruiting
Get alerts when Chengdu Kanghong Biotech Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free